Affiliation:
1. Department of Medicine, University of Washington School of Medicine, Division of Endocrinology and Metabolism, and the Geriatric Research, Education, and Clinical Center at the Veterans Administration Medical Center Seattle, Washington
Abstract
To determine the effect of tolbutamide on insulin release to nonglucose stimuli in non-insulin-dependent diabetes mellitus and how plasma glucose levels may modulate this effect, the acute insulin response (AIR) to an isoproterenol (12 μg) or an arginine (5 g) i.v. pulse was determined before and during a tolbutamide infusion (7.5 mg/m2/min) in 25 male subjects. During the tolbutamide infusion, there was an increase in the AIR to both isoproterenol (% Δ AIR = +49 ± 21%, N = 11, P < 0.05) and arginine (% Δ AIR = +52 ± 15%, N = 12, P < 0.005) and a decrease in plasma glucose (Δ plasma glucose for isoproterenol = −24 ± 6 mg/dl, P < 0.005; for arginine = −26 ± 3 mg/dl, P < 0.001). In separate studies, when the plasma glucose was clamped at baseline values by a variable rate of glucose infusion, there was a greater effect of tolbutamide on AIR when compared with the unclamped tolbutamide studies (isoproterenol: % Δ AIR = +132 ± 25%, P < 0.025; arginine: % Δ AIR = +95 ± 12%, P < 0.05). Thus, tolbutamide increases the AIR of nonglucose stimuli, but this augmentation by tolbutamide is blunted by the concomitant decrease in plasma glucose. Consideration of this observation is necessary when interpretating the effects of a sulfonylurea on islet cell responses.
Publisher
American Diabetes Association
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献